<DOC>
	<DOCNO>NCT01006265</DOCNO>
	<brief_summary>This study ass efficacy , safety , tolerability ACT-128800 patient relapsing-remitting multiple sclerosis .</brief_summary>
	<brief_title>Clinical Study Evaluate Efficacy , Safety , Tolerability ACT-128800 Patients With Relapsing-remitting Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Adult male female Diagnosis RRMS define revise ( 2005 ) McDonald Diagnostic Criteria Multiple Sclerosis ( MS ) . Signed inform consent prior initiation studymandated procedure . A diagnosis MS categorize primary progressive secondary progressive progressive relapsing . Patients currently treat autoimmune disorder MS. Contraindications MRI . Ongoing bacterial , viral , fungal infection . History presence malignancy . Additional inclusion exclusion criterion apply respect medical condition concomitant treatment could affect patient ' risk participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>